Obesity, albuminuria, and gamma-glutamyl transferase predict incidence of hypertension in indigenous Australians in rural and remote communities in northern Australia

Journal of Hypertension

Volumn 33, Issue 4, 2015, Pages 704-710

  Li, Ming ^a   McDermott, Robyn ^a,b  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b JAMES COOK UNIVERSITY   (Australia)

Author keywords

Albuminuria; Australian indigenous population; Gamma glutamyl transferase; Incidence of hypertension; Overweight and obesity

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; CHOLESTEROL; CREATININE; GAMMA-GLUTAMYLTRANSFERASE, HUMAN; GLUCOSE BLOOD LEVEL;

ABDOMINAL OBESITY; ADULT; ALBUMINURIA; ALCOHOL CONSUMPTION; AUSTRALIA; AUSTRALIAN ABORIGINE; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DRINKING BEHAVIOR; DYSLIPIDEMIA; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INCIDENCE; INDIGENOUS AUSTRALIAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RURAL AREA; SMOKING; SYSTOLIC BLOOD PRESSURE; TORRES STRAIT ISLANDER; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; ADOLESCENT; AGED; BLOOD; BLOOD PRESSURE MEASUREMENT; FOLLOW UP; METABOLISM; MIDDLE AGED; OCEANIC ANCESTRY GROUP; PREVALENCE; PROPORTIONAL HAZARDS MODEL; QUEENSLAND; RURAL POPULATION; STATISTICS AND NUMERICAL DATA; URINE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALBUMINURIA; ALCOHOL DRINKING; AUSTRALIA; BLOOD GLUCOSE; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; BODY WEIGHT; CHOLESTEROL; CREATININE; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; OBESITY; OCEANIC ANCESTRY GROUP; PREVALENCE; PROPORTIONAL HAZARDS MODELS; QUEENSLAND; RURAL POPULATION; SMOKING; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84938952904     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000462     Document Type: Conference Paper

References (41)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of world-wide data. Lancet 2005; 365:217-223.
2. Australian Bureau of Statistics. Australian Health Survey 2011/12 (4364.0) October 2012. http://www.abs.gov.au/AUSSTATS/absnsf/ Latestproducts/322DB1B539ACCC6CCA257B39000F316C?opendocument. [Accessed 15 May 2014].
3. Begg S, Vos T, Barker B, Stevenson C, Stanley L, Lopez AD. The burden of disease and injury in Australia 2003. PHE82. Canberra: AIHW; 2007.
4. Hajjar I, Kotchen JM, Kotchen TA. Hypertension: trends in prevalence, incidence, and control. Annu Rev Public Health 2006; 27:465-490.
5. Ferrannini E, Cushman WC. Diabetes and hypertension: the bad companions. Lancet 2012; 380:601-610.
6. Xun P, Wu Y, He Q, He K. Fasting insulin concentrations and incidence of hypertension, stroke, and coronary heart disease: a meta-analysis of prospective cohort studies. Am J Clin Nutr 2013; 98:1543-1554.
7. Australian Institute of Health and Welfare. The health and welfare of Australian's Aboriginal and Torres Strait Islander people, an overview 2011. Cat. No. IHW42 Canberra: AIHW; 2011.
8. Wang Z, Sabina K, Wilson A, Rowley KG, Best JD, McDermott R, et al. Blood pressure and hypertension for Australian Aboriginal and Torres Strait Islander people. Eur J Cardiovasc Prev Rehabil 2006; 13:438-443.
9. McDermott RA, Li M, Campbell SK. Incidence of type 2 diabetes in two indigenous Australian populations: a 6-year follow-up study. Med J Aust 2010; 192:562-565.
10. McDermott RA, McCulloch B, Li M. Glycaemia and albuminuria as predictors of coronary heart disease in Aboriginal and Torres Strait Islander adults: a north Queensland cohort. Med J Aust 2011; 194:514-518.
11. Miller G, McDermott R, McCulloch B, Leonard D, Arabena K, Muller R. The Well Person's Health Check: a population screening program in indigenous communities in north Queensland. Aust Health Rev 2002; 25:136-147.
12. Australian Bureau of Statistics. National nutrition survey: nutrient intakes and physical measurements, Australia, 1995. Catalogue no. 4805.0. Canberra: ABS; 1998.
13. National Health and Medical Research Council. Eating for health: Australian Dietary Guidelines. NHMRC: N55a. Canberra. 2013. http://www.nhmrc.gov.au. [Accessed 20 May 2014].
14. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Expert Committee. WHO Technical Report Series no. 894. Geneva: WHO; 1998.
15. Perseghin G, Lattuada G, De Cobelli F, Ragogna F, Ntali G, Esposito A, et al. Habitual physical activity is associated with intrahepatic fat content in humans. Diabetes Care 2007; 30:683-688.
16. Barr ELM, Magliano DJ, Zimmet PZ, Polkinghorne KR, Atkins RC, Dunstan DW, et al. The Australian diabetes, obesity and lifestyle study: AusDiab 2005. International Diabetes Institute, Melbourne, Australia; 2006.
17. World Health Organization. Part 1: diagnosis and classification of diabetes mellitus. In Definition, diagnosis and classification of diabetes mellitus and its complications. Geneva: Department of Noncommunicable Disease Surveillance, WHO; 1999.
18. National Heart Foundation and Australian Institute of Health and Welfare. Risk factor prevalence study no. 3 1989. Canberra: National Heart Foundation and Australian Institute of Health; 1990.
19. Baker IDI-Heart &Diabetes Institute. Key findings from the five year follow-up survey in 2004/2005. https://www.bakeridi.edu.au/ausdiab/ keyfindings/. [Accessed 23 May 2014].
20. Carson AP, Howard G, Burke G, Shea S, Levitan EB, Muntner P, et al. Ethnic differences in hypertension incidence among middle-aged and older adults. The Multi-Ethnic Study of Atherosclerosis. Hypertension 2011; 57:1101-1107.
21. Wang W, Lee ET, Fabsitz RR, Devereux R, Best L, Welty TK, et al. A longitudinal study of hypertension risk factors and their relation to cardiovascular disease. The Strong Heart Study. Hypertension 2006; 47:403-409.
22. Hu G, Barengo NC, Tuomilehto J, Lakka TA, Nissinen A, Jousilahti P. Relationship of physical activity and body mass index to the risk of hypertension: a prospective study in Finland. Hypertension 2004; 43:25-30.
23. Shihab HM, Meoni LA, Chu AY, Wang NY, Ford DE, Liang KY, et al. Body mass index and risk of incident hypertension over the life course: the Johns Hopkins Precursors Study. Circulation 2012; 126:2983-2989.
24. Gelber RP, Gaziano JM, Manson JE, Buring JE, Sesso HD. A prospective study of body mass index and the risk of developing hypertension in men. Am J Hypertens 2007; 20:370-377.
25. Chuang SY, Chou P, Hsu PF, Cheng HM, Tsai ST, Lin IF, Chen CH. Presence and progression of abdominal obesity are predictors of future high blood pressure and hypertension. Am J Hypertens 2006; 19:788-795.
26. Echouffo-Tcheugui JB, Batty GD, Kivimaki M, Kengne AP. Risk models to predict hypertension: a systematic review. PLoS One 2013; 8:e67370.
27. Huxley R, Barzi F, Lee CMY, Janus E, Lam TH, Caterson I, et al. Is central obesity a better discriminator of the risk of hypertension than body mass index in ethnically diverse populations. The Obesity in Asia Collaboration. J Hypertens 2008; 26:169-177.
28. DeMarco VG, Aroor AR, Sowers JR. The pathophysiology of hypertension in patients with obesity. Nature Rev Endocrinol 2014; 10:364-376.
29. Wang TJ, Evans JC, Meigs JB, Rifai N, Fox CS, D'Agostino RB, et al. Lowgrade albuminuria and the risks of hypertension and blood pressure progression. Circulation 2005; 111:1370-1376.
30. Forman JP, Fisher ND, Schopick EL, Curhan GC. Higher levels of albuminuria within the normal range predict incident hypertension. J Am Soc Nephrol 2008; 19:1983-1988.
31. Brantsma AH, Bakker SJ, de Zeeuw D, de Jong PE, Gansevoort RT. Urinary albumin excretion as a predictor of the development of hypertension in the general population. J Am Soc Nephrol 2006; 17:331-335.
32. Jessani S, Levey AS, Chaturvedi N, Jafar TH. High normal levels of albuminuria and risk of hypertension in Indo-Asian population. Nephrol Dial Transplant 2012; 27 (Supple 3):iii58-iii64.
33. Matsushita K, van Der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375:2073-2081.
34. de Zeeuw D, Parving HH, Henning RH. Microalbuminuria as an early marker for cardiovascular disease. J Am Soc Nephrol 2006; 17:2100-2105.
35. Campese VM, Mitra N, Sandee D. Hypertension in renal parenchymal disease: why is it so resistant to treatment? Kidney Int 2006; 69:967-973.
36. Deckert T, Feldt-Rasmussen BG, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989; 32:219-226.
37. Maple-Brown LJ, Cunningham J, Hodge AM, Weeramanthri T, Dunbar T, Lawton PD, et al. High rates of albuminuria but of low eGFR in urban indigenous Australians: the DRUID Study. BMC Public Health 2011; 11:346.
38. Liu CF, Gu YT, Wang HY, Fang NY. Gamma-glutamyl transferase level and risk of hypertension: a systematic review and meta-analysis. PLoS One 2012; 7:e48878.
39. Li M, Campbell S, McDermott R. g-Glutamyltransferase, obesity, physical activity, and the metabolic syndrome in indigenous Australian adults. Obesity 2009; 17:809-813.
40. Lee DH, Jacobs DR Jr, Gross M, Kiefe CI, Roseman J, Lewis CE, Steffes M. Gamma glutamyl transferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 2003; 49:1358-1366.
41. Lee DH, Blomhoff R, Jacobs DR Jr. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res 2004; 38:535-539.